Most recently, it has been determined that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in similar spots as classical opioid receptors, it binds to your big selection of endogenous opioids. Not like most opioid receptors, this receptor acts to be a scavenger and will not activate a second